Alvotech (ALVO) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ALVO Stock Forecast


Alvotech stock forecast is as follows: an average price target of $16.00 (represents a 33.44% upside from ALVO’s last price of $11.99) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.

ALVO Price Target


The average price target for Alvotech (ALVO) is $16.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $22.00 to $10.00. This represents a potential 33.44% upside from ALVO's last price of $11.99.

ALVO Analyst Ratings


Hold

According to 3 Wall Street analysts, Alvotech's rating consensus is 'Hold'. The analyst rating breakdown for ALVO stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Alvotech Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 24, 2024Balaji PrasadBarclays--62.00%83.49%
May 21, 2024Balaji PrasadBarclays--45.35%66.81%
Jan 29, 2024Balaji PrasadBarclays--11.48%41.78%
Jul 01, 2022Emmanuel PapadakisDeutsche Bank--21.80%-16.60%
Row per page
Go to

The latest Alvotech stock forecast, released on May 24, 2024 by Balaji Prasad from Barclays, set a price target of $22.00, which represents a 62.00% increase from the stock price at the time of the forecast ($13.58), and a 83.49% increase from ALVO last price ($11.99).

Alvotech Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$19.67
Last Closing Price$11.99$11.99$11.99
Upside/Downside-100.00%-100.00%64.05%

In the current month, the average price target of Alvotech stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alvotech's last price of $11.99. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
May 21, 2024BarclaysOverweightOverweightHold
Jan 29, 2024BarclaysOverweightUpgrade
Oct 20, 2023CitigroupNeutralUpgrade
Jul 01, 2022Deutsche BankHoldInitialise
Row per page
Go to

Alvotech's last stock rating was published by Barclays on May 21, 2024. The company gave ALVO a "Overweight" rating, the same as its previous rate.

Alvotech Financial Forecast


Alvotech Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
Revenue---------
Avg Forecast$333.94M$306.27M$280.90M$257.63M$87.50M$85.00M$198.75M$93.00M$42.00M
High Forecast$359.65M$329.85M$302.52M$277.46M$98.69M$91.54M$214.05M$100.16M$45.23M
Low Forecast$308.23M$282.70M$259.28M$237.79M$76.31M$78.46M$183.45M$85.84M$38.77M
# Analysts111111111
Surprise %---------

Alvotech's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ALVO's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Alvotech EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111111111
EBITDA---------
Avg Forecast$-259.90M$-238.37M$-218.62M$-200.51M$-68.10M$-66.15M$-154.69M$-72.38M$-32.69M
High Forecast$-239.89M$-220.02M$-201.79M$-185.07M$-59.39M$-61.06M$-142.78M$-66.81M$-30.17M
Low Forecast$-279.91M$-256.72M$-235.45M$-215.94M$-76.81M$-71.25M$-166.59M$-77.95M$-35.20M
Surprise %---------

undefined analysts predict ALVO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alvotech's previous annual EBITDA (undefined) of $NaN.

Alvotech Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111111111
Net Income---------
Avg Forecast$18.11M$23.28M$2.59M$5.17M$2.59M$-16.30M$776.02K$10.86M$-36.21M
High Forecast$19.92M$25.61M$2.85M$5.69M$2.85M$-14.67M$853.68K$11.95M$-32.59M
Low Forecast$16.30M$20.95M$2.33M$4.66M$2.33M$-17.93M$698.36K$9.78M$-39.84M
Surprise %---------

Alvotech's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALVO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Alvotech SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111111111
SG&A---------
Avg Forecast$519.64M$476.59M$437.10M$400.89M$136.16M$132.27M$309.28M$144.72M$65.36M
High Forecast$559.64M$513.27M$470.75M$431.75M$153.56M$142.45M$333.08M$155.86M$70.39M
Low Forecast$479.64M$439.90M$403.45M$370.03M$118.75M$122.08M$285.47M$133.58M$60.32M
Surprise %---------

Alvotech's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ALVO last annual SG&A of $NaN (undefined).

Alvotech EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23
# Analysts111111111
EPS---------
Avg Forecast$0.07$0.09$0.01$0.02$0.01$-0.06-$0.04$-0.14
High Forecast$0.08$0.10$0.01$0.02$0.01$-0.06-$0.05$-0.13
Low Forecast$0.06$0.08$0.01$0.02$0.01$-0.07-$0.04$-0.15
Surprise %---------

According to undefined Wall Street analysts, Alvotech's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALVO previous annual EPS of $NaN (undefined).

Alvotech Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ASRTAssertio--206.38%Buy
PCRXPacira BioSciences--99.43%Hold
AMPHAmphastar Pharmaceuticals--45.18%Buy
ANIPANI Pharmaceuticals--38.82%Buy
COLLCollegium Pharmaceutical--35.18%Buy
ALVOAlvotech--33.44%Hold
CYTHCyclo Therapeutics--30.14%Buy
ALKSAlkermes--26.41%Hold
CTLTCatalent--21.76%Hold
ITCIIntra-Cellular Therapies--10.28%Buy
LFCRLifecore Biomedical---11.08%Buy

ALVO Forecast FAQ


Is Alvotech a good buy?

No, according to 3 Wall Street analysts, Alvotech (ALVO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 33.33% of ALVO's total ratings.

What is ALVO's price target?

Alvotech (ALVO) average price target is $16 with a range of $10 to $22, implying a 33.44% from its last price of $11.99. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Alvotech stock go up soon?

According to Wall Street analysts' prediction for ALVO stock, the company can go up by 33.44% (from the last price of $11.99 to the average price target of $16), up by 83.49% based on the highest stock price target, and down by -16.60% based on the lowest stock price target.

Can Alvotech stock reach $20?

ALVO's highest twelve months analyst stock price target of $22 supports the claim that Alvotech can reach $20 in the near future.

What are Alvotech's analysts' financial forecasts?

Alvotech's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $371.25M (high $404.28M, low $338.22M), average EBITDA is $-289M (high $-263M, low $-315M), average net income is $-12.934M (high $-10.966M, low $-14.901M), average SG&A $577.7M (high $629.09M, low $526.3M), and average EPS is $-0.05 (high $-0.0424, low $-0.0576). ALVO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.18B (high $1.27B, low $1.09B), average EBITDA is $-917M (high $-847M, low $-988M), average net income is $49.15M (high $54.07M, low $44.23M), average SG&A $1.83B (high $1.98B, low $1.69B), and average EPS is $0.19 (high $0.209, low $0.171).